SEC Form 4 · accession 0001181431-15-003280
Sagent Pharmaceuticals, Inc. · SGNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lorin Drake
Officer — Executive VP, Sales
Period of report
Feb 21, 2015
Accepted (ET)
Feb 24, 2015 · 6:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369786
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 21, 2015 | F | 449 | $28.50 | D | 24,512 | D | |
| Common Stock | Feb 22, 2015 | F | 293 | $28.50 | D | 24,219 | D |
Table II — derivative securities
No Table II lines on this filing.